Literature DB >> 15215161

Molecular analysis of the human autoantibody response to alpha-fodrin in Sjögren's syndrome reveals novel apoptosis-induced specificity.

Toshiaki Maruyama1, Ichiro Saito, Yoshio Hayashi, Elizabeth Kompfner, Robert I Fox, Dennis R Burton, Henrik J Ditzel.   

Abstract

Lymphocyte infiltration of salivary and lacrimal glands leading to diminished secretion and gland destruction as a result of apoptosis is thought to be pivotal in the pathogenesis of Sjögren's syndrome (SS). The cytoskeletal protein alpha-fodrin is cleaved during this apoptotic process, and a strong antibody (Ab) response is elicited to a 120-kd fragment of cleaved alpha-fodrin in the majority of SS patients, but generally not in other diseases in which apoptosis also occurs. Little is known about the anti-alpha-fodrin autoantibody response on a molecular level. To address this issue, IgG phage display libraries were generated from the bone marrow of two SS donors and a panel of anti-alpha-fodrin IgGs was isolated by selection on alpha-fodrin immunoblots. All of the human monoclonal Abs (hmAbs) reacted with a 150-kd fragment and not with the 120-kd fragment or intact alpha-fodrin, indicating that the epitope recognized became exposed after alpha-fodrin cleavage. Analysis of a large panel of SS patients (defined by the strict San Diego diagnostic criteria) showed that 25% of SS sera exhibited this 150-kd alpha-fodrin specificity. The hmAbs stained human cultured salivary acinar cells and the staining was redistributed to surface blebs during apoptosis. They also stained inflamed acinar/ductal epithelial cells in SS salivary tissue biopsies, and only partially co-localized with monoclonal Abs recognizing the full-length alpha-fodrin. Our study shows that in SS patients, neoepitopes on the 150-kd cleaved product of alpha-fodrin become exposed to the immune system, frequently eliciting anti-150-kd alpha-fodrin Abs in addition to the previously reported anti-120-kd Abs. The anti-150-kd alpha-fodrin hmAbs may serve as valuable reagents for the study of SS pathogenesis and diagnostic analyses of SS salivary gland tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215161      PMCID: PMC1618543          DOI: 10.1016/s0002-9440(10)63274-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Ebola virus can be effectively neutralized by antibody produced in natural human infection.

Authors:  T Maruyama; L L Rodriguez; P B Jahrling; A Sanchez; A S Khan; S T Nichol; C J Peters; P W Parren; D R Burton
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Neonatal lupus erythematosus: maternal IgG antibodies bind to a recombinant NH2-terminal fusion protein encoded by human alpha-fodrin cDNA.

Authors:  S Miyagawa; K Yanagi; A Yoshioka; K Kidoguchi; T Shirai; Y Hayashi
Journal:  J Invest Dermatol       Date:  1998-12       Impact factor: 8.551

3.  Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis.

Authors:  R Nath; K J Raser; D Stafford; I Hajimohammadreza; A Posner; H Allen; R V Talanian; P Yuen; R B Gilbertsen; K K Wang
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

4.  Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through fas-mediated apoptosis.

Authors:  N Ishimaru; K Saegusa; K Yanagi; N Haneji; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

5.  Anti-alpha-fodrin antibodies in Sjögren syndrome and lupus erythematosus.

Authors:  T Watanabe; T Tsuchida; N Kanda; K Mori; Y Hayashi; K Tamaki
Journal:  Arch Dermatol       Date:  1999-05

6.  Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis.

Authors:  D M Vanags; M I Pörn-Ares; S Coppola; D H Burgess; S Orrenius
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

7.  Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.

Authors:  N Haneji; T Nakamura; K Takio; K Yanagi; H Higashiyama; I Saito; S Noji; H Sugino; Y Hayashi
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

8.  Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis.

Authors:  R U Jänicke; P Ng; M L Sprengart; A G Porter
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

9.  Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.

Authors:  K Yanagi; N Ishimaru; N Haneji; K Saegusa; I Saito; Y Hayashi
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

Review 10.  Evolving concepts of diagnosis, pathogenesis, and therapy of Sjögren's syndrome.

Authors:  R I Fox; J Törnwall; T Maruyama; M Stern
Journal:  Curr Opin Rheumatol       Date:  1998-09       Impact factor: 5.006

View more
  4 in total

1.  Successful treatment of a patient with primary Sjögren's syndrome with Rituximab.

Authors:  Troels Ring; Maria Kallenbach; Jeppe Praetorius; Søren Nielsen; Birgitte Melgaard
Journal:  Clin Rheumatol       Date:  2005-11-08       Impact factor: 2.980

2.  Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.

Authors:  Abhishek Chandra; Gary P Wormser; Mark S Klempner; Richard P Trevino; Mary K Crow; Norman Latov; Armin Alaedini
Journal:  Brain Behav Immun       Date:  2010-03-18       Impact factor: 7.217

3.  Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy.

Authors:  Livia Casciola-Rosen; Kanneboyina Nagaraju; Paul Plotz; Kondi Wang; Stuart Levine; Edward Gabrielson; Andrea Corse; Antony Rosen
Journal:  J Exp Med       Date:  2005-02-21       Impact factor: 14.307

Review 4.  Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?

Authors:  Kevin Didier; Loïs Bolko; Delphine Giusti; Segolene Toquet; Ailsa Robbins; Frank Antonicelli; Amelie Servettaz
Journal:  Front Immunol       Date:  2018-03-26       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.